Skip to main content
. 2013 May 29;142(2):270–286. doi: 10.1017/S0950268813000940

Fig. 1.

Fig. 1.

Prevalence of antibodies to hepatitis C virus (anti-HCV) and hepatitis B surface antigen (HBsAg) in (a) the general adult population; (b) people who inject drugs (PWID) in the WHO European region, by country. Hatched areas on maps indicate countries outside the WHO European Region.